Advancement of Digital Media in the Pharma Sector
Senior members of Fleishman-Hillard’s global healthcare and digital teams join forces for an enlightening look at the “evolution of thought” surrounding Web 2.0 and the healthcare industry. Topics discussed include the increased role social media is playing in patient decisions, lack of clear direction from the FDA despite new leadership, and the agency’s current “vacuum of information” with regard to digital communications and the pharma sector.
Watch: The Evolution of Web 2.0 Marketing in the Pharmaceutical Sector
Posted on April 7th, 2009 | More Digital & Social Media · Healthcare
-
Is social media marketing responsible for the “impending demise” of email? The digital specialists from Fleishman DNA
examine the platform’s decline, including how the changes could affect brands.
Posted on February 8th, 2012 | More B2C · Digital & Social Media · Mobile · Small Business Owners
-
While Facebook prepares to go public, communicators appear to be in for a huge learning experience. In a PRWeek article, International Advisory Board member John Onoda weighs in — and suggests we’ll see “a new chapter of PR unfold.”
Read: Facebook From the 50-Yard Line
Posted on February 8th, 2012 | More Analysts & Investors · Digital & Social Media · Financial Communications
-
In an article in PharmaVoice, pharma specialist Mark Senak
discusses pharmacovigilance communication and explains why the best digital strategy includes “the concept of a two-way exchange.”
Read: Best Practices in Pharmacovigilance
Posted on February 3rd, 2012 | More Crisis Communications · Digital & Social Media · Healthcare
